Trial Profile
A Randomized, Double Blind, Multicenter Phase III Trial to Evaluate the Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2020
Price :
$35
*
At a glance
- Drugs Palonosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 21 Oct 2013 Status changed from recruiting to completed.
- 16 Oct 2013 Results presented at the 2013 Annual Meeting of the American Society of Anesthesiologists.
- 11 Apr 2012 New trial record